69
Participants
Start Date
July 31, 2002
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
ritonavir
ritonavir oral capsules or oral solution
fosamprenavir
fosamprenavir oral suspension or tablet
GSK Investigational Site, Lisbon
GSK Investigational Site, Amadora
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, The Bronx
GSK Investigational Site, Genoa
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Richmond
GSK Investigational Site, Pavia
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Jacksonville
GSK Investigational Site, Tampa
GSK Investigational Site, Padua
GSK Investigational Site, Birmingham
GSK Investigational Site, Seville
GSK Investigational Site, Modena
GSK Investigational Site, Cleveland
GSK Investigational Site, Valencia
GSK Investigational Site, Florence
GSK Investigational Site, Chicago
GSK Investigational Site, New Orleans
GSK Investigational Site, Dallas
GSK Investigational Site, Fort Worth
GSK Investigational Site, Los Angeles
GSK Investigational Site, Boston
GSK Investigational Site, Stony Brook
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Rome
GSK Investigational Site, Rotterdam
GSK Investigational Site, Lisbon
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Palma de Mallorca
Lead Sponsor
ViiV Healthcare
INDUSTRY